Health Canada approves Biocon micafungin Monday, Biocon shares rise 1.9%
NewsBytes | May 11, 2026 2:39 PM CST
Biocon profit nearly 57% last quarter
Even though Biocon's net profit dropped nearly 57% last quarter, its stock has climbed 12% this past month, showing investors are still optimistic, especially with this new approval in hand.
Chairperson Kiran Mazumdar-Shaw shared that her niece Claire will take over leadership over the next five years, while the current management keeps things running smoothly.
READ NEXT
-
'My neighbour's daughter is so lazy that it kicked off on bin day'
-
Sky News meltdown as Beth Rigby abandons interview after mic blunder
-
Ed Balls' future on GMB is crumbling more than Keir Starmer's place in No. 10
-
Mumbai Faces Water Supply Cut Amid Dwindling Reservoir Levels
-
UK fashion retailer closing down shops forever - in business for 9 years
